A Combined Endoscopy and Radiology-guided Radiofrequency Ablation Therapy Protocol for Inoperable Perihilar Cholangiocarcinoma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
- 试验地点
- 2
- 主要终点
- Technical success of ERCP procedure
研究概览
简要总结
This prospective clinical trial aims to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma.
详细描述
This clinical trial proposes a personalized treatment approach to inoperable perihilar cholangiocarcinoma consisting of endoluminal ablative therapy via radiofrequency ablation followed by endoscopic biliary drainage.
Patients presenting with jaundice / biliary obstruction caused by inoperable perihilar cholangiocarcinoma as assessed during multidisciplinary case discussion will be invited to enroll in this trial.
Patients will be randomized in a 1:1 fashion to receive biliary plastic stenting (control arm) or biliary plastic stenting + radiofrequency ablation via endoscopic approach. In cases where ERCP fails to achieve adequate biliary drainage, stenting and/or drainage will be attempted via percutaneous approach.
Additional systemic chemotherapy will be offered to all eligible patients according to the local standard of care.
Patients will be followed up with a clinical visit at 2 weeks and stent exchange (+ additional RFA treatment in the control arm) will be offered at 8-12 weeks interval until disease progression, clinical deterioration precluding ERCP or death.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •perihilar cholangiocarcinoma
- •locally advanced disease (unresectable)
- •M1 (limted to 1 site)
排除标准
- •refusal to sogn the ICF
- •poor performance status (ECOG >2)
- •surgically altered anatomy (i.e Bilroth II or Roux-en-Y interventions)
- •significant comorbidities
- •ASA score >3
- •life expectancy <3 months
研究组 & 干预措施
COMBO-RFA Arm
Patients randomized to this arm will undergo same-session endoluminal radiofrequency ablation followed by biliary stenting
干预措施: Endoluminal radiofrequency ablation (Procedure)
COMBO-RFA Arm
Patients randomized to this arm will undergo same-session endoluminal radiofrequency ablation followed by biliary stenting
干预措施: Endoscopic biliary stenting (Procedure)
Endoscopic Drainage Arm
Patients randomized to this arm will undergo biliary stenting only
干预措施: Endoscopic biliary stenting (Procedure)
结局指标
主要结局
Technical success of ERCP procedure
时间窗: 2 months
Ability to correctly apply radiofrequency ablation and place stents in all the biliary ducts accessed on ERCP
Tumor response
时间窗: 6 months
To evaluate the efficacy of radiofrequency ablation in local disease control by assessing tumor response according to RECIST criteria at 6 months follow-up
次要结局
- Rate of procedure-related adverse events(12 months)
- Overall survival(12 months)
- Tumor microenvironment alterations(2 months)
研究者
dr. Theodor Alexandru Voiosu
Gastroenterology Consultant
Clinical Hospital Colentina
